Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by M&T Bank Corp

M&T Bank Corp decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 3,937 shares of the biotechnology company’s stock after selling 744 shares during the period. M&T Bank Corp’s holdings in Axon Enterprise were worth $1,574,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Public Sector Pension Investment Board grew its position in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the period. CIBC Asset Management Inc increased its stake in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after buying an additional 895 shares in the last quarter. Foundations Investment Advisors LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC raised its holdings in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the third quarter worth approximately $814,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of Axon Enterprise stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. The trade was a 1.76 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 99,590 shares of company stock valued at $49,176,907 over the last 90 days. 6.10% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on AXON shares. Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $488.67.

Axon Enterprise Stock Up 1.3 %

Shares of NASDAQ:AXON opened at $644.91 on Friday. The company has a market capitalization of $49.17 billion, a price-to-earnings ratio of 166.64, a PEG ratio of 14.14 and a beta of 1.01. Axon Enterprise, Inc. has a 12-month low of $241.72 and a 12-month high of $698.67. The business has a 50-day moving average price of $539.52 and a 200 day moving average price of $405.45. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.